Mei Dong

804 total citations
22 papers, 613 citations indexed

About

Mei Dong is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Mei Dong has authored 22 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Mei Dong's work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (6 papers) and Biochemical and Molecular Research (5 papers). Mei Dong is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (6 papers) and Biochemical and Molecular Research (5 papers). Mei Dong collaborates with scholars based in China, Australia and Czechia. Mei Dong's co-authors include Di Wang, Xiaoxing Cheng, Zhihong Cao, Linhai Li, Qingjun Ma, Ping Li, Yuling Shi, Yourong Yang, Jian‐Guo Wang and Yuankai Shi and has published in prestigious journals such as Clinical Cancer Research, Journal of Clinical Microbiology and Clinica Chimica Acta.

In The Last Decade

Mei Dong

22 papers receiving 602 citations

Peers

Countries citing papers authored by Mei Dong

Since Specialization

Citations

This map shows the geographic impact of Mei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Dong more than expected).

Fields of papers citing papers by Mei Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Dong. The network helps show where Mei Dong may publish in the future.

Co-authorship network of co-authors of Mei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Dong. A scholar is included among the top collaborators of Mei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Dong. Mei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents 2023 ·Traditional Medicine Research ·Shufan Wang, (unknown), (unknown), Wenxin Lin, Mei Dong, Duo Liu	3
2	Antibiotic resistance patterns of Gram-negative and Gram-positive strains isolated from inpatients with nosocomial infections in a tertiary hospital in Beijing, China from 2011 to 2014 2016 ·Journal of Chemotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Mei Dong	9
3	Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase 2015 ·European Journal of Medicinal Chemistry ·Wei Lu, (unknown), (unknown), Changjun Cui, Rui Guo, (unknown), Di Wang, Mei Dong, Moon‐Young Yoon, Jian‐Guo Wang	55
4	In Vitro Activity of Novel Oxazolidinone Analogs and 13 Conventional Antimicrobial Agents against Clinical Isolates of Staphylococcus aureus in Beijing, China 2014 ·Japanese Journal of Infectious Diseases ·Lei Hong, Ying Jiang, Di Wang, Ping Gong, Yanyan Li, (unknown), Mei Dong	7
5	Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses 2014 ·Clinical Cancer Research ·Yuankai Shi, (unknown), Jiatao Lou, Xiaohong Han, Lijian Zhang, Qingtao Wang, Baolan Li, Mei Dong, Yinghong Zhang	87
6	Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis 2013 ·Current Drug Targets ·(unknown), Zhijian Xu, Zhuo Yang, Yingtao Liu, Di Wang, Mei Dong, Emily J. Parker, Weiliang Zhu	7
7	Discovery of Novel Acetohydroxyacid Synthase Inhibitors as Active Agents againstMycobacterium tuberculosisby Virtual Screening and Bioassay 2013 ·Journal of Chemical Information and Modeling ·Di Wang, Xuelian Zhu, Changjun Cui, Mei Dong, Hualiang Jiang, Zhengming Li, Zhen Liu, Weiliang Zhu, Jian‐Guo Wang	40
8	In Vitro Activity of Linezolid against Clinical Isolates of Mycobacterium tuberculosis, including Multidrug-Resistant and Extensively Drug-Resistant Strains from Beijing, China 2012 ·Japanese Journal of Infectious Diseases ·(unknown), Lei Hong, Di Wang, Xianghong Meng, (unknown), (unknown), (unknown), Ying Jiang, Mei Dong	24
9	Evaluation of the in vitro and intracellular efficacy of new monosubstituted sulfonylureas against extensively drug-resistant tuberculosis 2012 ·International Journal of Antimicrobial Agents ·Di Wang, Pan Li, Gang Cao, Lei Hong, Xianghong Meng, (unknown), Mei Dong, Zhengming Li, Zhen Liu	18
10	Establishing a serologic decision tree model of extrapulmonary tuberculosis by MALDI-TOF MS analysis 2011 ·Diagnostic Microbiology and Infectious Disease ·(unknown), Minggui Lin, Chaojun Hu, Yanfeng Li, Yang Gao, Xiaoxing Cheng, Fengchun Zhang, Mei Dong, Yongzhe Li	13
11	Antimicrobial Susceptibility Patterns of Clinical Isolates of Gram-Negative Bacteria Obtained from Intensive Care Units in a Tertiary Hospital in Beijing, China 2011 ·Journal of Chemotherapy ·Xianghong Meng, Mei Dong, (unknown), (unknown), (unknown), (unknown), (unknown)	7
12	Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis 2011 ·Journal of Infection ·Xinjing Wang, Zhihong Cao, Jing Jiang, Yanfeng Li, Mei Dong, Mario Ostrowski, Xiaoxing Cheng	41
13	In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China. 2011 ·PubMed ·Mei Dong, (unknown), Ying Jiang, Li Zhao, (unknown), Chun Wu	9
14	Reduced CD27 Expression on Antigen-Specific CD4+ T Cells Correlates with Persistent Active Tuberculosis 2010 ·Journal of Clinical Immunology ·Jing Jiang, Xianyuan Wang, Xinjing Wang, Zhihong Cao, Yanhua Liu, Mei Dong, (unknown), Xiaoxing Cheng	31
15	Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis 2010 ·Clinica Chimica Acta ·Xueqiong Wu, Yourong Yang, Junxian Zhang, (unknown), Yan Liang, (unknown), Mei Dong	40
16	Humoral Immune Responses against theMycobacteriumtuberculosis38-Kilodalton, MTB48, and CFP-10/ESAT-6 Antigens in Tuberculosis 2010 ·Clinical and Vaccine Immunology ·Xueqiong Wu, Yourong Yang, Junxian Zhang, (unknown), Yan Liang, (unknown), Mei Dong, (unknown), (unknown)	43
17	Association of mycobacterial antigen-specific CD4+ memory T cell subsets with outcome of pulmonary tuberculosis 2009 ·Journal of Infection ·Xinjing Wang, Zhihong Cao, Jing Jiang, (unknown), Mei Dong, (unknown), Xiaoxing Cheng	39
18	Pathological findings in rats with experimental allergic encephalomyelitis 2008 ·Apmis ·Mei Dong, Ruichun Liu, (unknown), Chunyan Li, Guo-Jun Tan	17
19	The Pathogenesis of Multiple Sclerosis 2006 ·Mei Dong	2
20	Diagnosis of Severe Acute Respiratory Syndrome (SARS) by Detection of SARS Coronavirus Nucleocapsid Antibodies in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay 2003 ·Journal of Clinical Microbiology ·Yuling Shi, (unknown), Ping Li, (unknown), Linhai Li, Mei Dong, Qingjun Ma, (unknown)	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact